Differential induction of apoptosis in oncogene-transformed NIH 3T3 cells by methylmethanesulfonate

Biochemical Pharmacology

Volumn 52, Issue 3, 1996, Pages 481-488

  Kuo, Min Liang ^a   Chou, Yi Wen ^a   Chau, Yat Pang ^b   Meng, Tzu Ching ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

apoptosis; Bcl 2 protein; glutathione; necrosis; NIH 3T3 cells; ras transformed NIH 3T3 cells

Indexed keywords

BUTHIONINE SULFOXIMINE; DNA; GLUTATHIONE; MESYLIC ACID METHYL ESTER; PROTEIN BCL 2;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL LINE; CELL STRAIN 3T3; CELL STRUCTURE; CELL TRANSFORMATION; CONTROLLED STUDY; DEPLETION; DNA DAMAGE; IMMUNOBLOTTING; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE H RAS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0030576640     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(96)00251-1     Document Type: Article

References (33)

1. 1. Wyllie AH, The biology of cell death in tumors. Anticancer Res 5: 131-142, 1985.
2. 2. Martin SJ, Lennon SV, Bonham AM and Cotter TG, Induction of apoptosis in human leukemia HL-60 cells by inhibition of RNA and protein synthesis. J Immunol 145: 1859-1863, 1990.
3. 3. Barry MA, Reynolds JE and Eastman A, Etoposide-induced apoptosis in human HL-60 cells is associated with intracellular acidification. Cancer Res 53: 2349-2357, 1993.
4. 4. Evans DL and Dive C, Effects of cisplatin on the induction of apoptosis in proliferating hepatoma cells and nonproliferating immature thymocytes. Cancer Res 53: 2133-2139, 1993.
5. 5. Barry MA, Behnke CA and Eastman A, Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 40: 2353-2362, 1990.
6. 6. Eastman A, Activation of programmed cell death by anticancer agents: Cisplatin as a model system. Cancer Cells (Cold Spring Harbor) 2: 275-280, 1990.
7. 7. Niimi S, Nakagawa K, Yokota J, Tsunokawa Y, Nishio K, Terashima Y, Shibuya M, Terada M and Saijo N, Resistance to anticancer drugs in NIH-3T3 cells transfected with c-myc and/or c-H-ras genes. Br J Cancer 63: 237-241, 1991.
8. 8. Burt RK, Garfield S, Johnson K and Thorgeirsson SS, Transformation of rat liver epithelial cells with v-H-ras or v-raf causes expression of MDR-1, glutathione-S-transferase-P and increased resistance to cytotoxic chemicals. Carcinogenesis 9: 2329-2332, 1988.
9. 9. Sakai N, Ogiso Y, Fujita H, Watari H, Koike T and Kuzumaki N, Induction of apoptosis by a dominant negative H-RAS mutant (116Y) in K562 cells. Exp Cell Res 215: 131-136, 1994.
10. 10. Blenis J, Signal transduction via the MAP kinases: Proceed at your own RSK. Proc Natl Acad Sci USA 90: 5889-5892, 1993.
11. ras. Trends Biochem Sci 18: 250-254, 1993.
12. 12. Mar J, Forging a path to the nucleus. Science 260: 1588-1590, 1993.
13. 13. Avruch J, Zhang X-F, and Kyriakis JM, Raf meets Ras: Completing the framework of a signal transduction pathway. Trends Biochem Sci 19: 279-283, 1994.
14. 14. Mordret G, MAP kinase kinase: A node connecting multiple pathways. Biol Cell 79: 193-207, 1993.
15. 15. Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, Vande Woude GF, and Ahn NG, Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265: 966-970, 1994.
16. 16. Nakagawa K, Saijo N, Tsuchida S, Sakai M, Tsunokawa Y, Yokota J, Muramatsu M, Sato K, Terada M and Tew KD, Glutathione-S-transferase π as a determinant of drug resistance in transfectant cell lines. J Biol Chem 265: 4296-4301, 1990.
17. 17. Kuo M-L, and Yang N-C, Reversion of v-H-ras-transformed NIH 3T3 cells by apigenin through inhibiting mitogen activated protein kinase and its downstream oncogenes. Biochem Biophys Res Commun 212: 767-775, 1995.
18. 18. Tsujimoto Y, Finger LR, Yunis J, Nowell PC and Croce CM, Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 226: 1097-1099, 1984.
19. 19. Caron-Leslie L-AM, Evans RB and Cidlowski JA, Bcl-2 inhibits glucocorticoid-induced apoptosis but only partially blocks calcium ionophore or cycloheximide-regulated apoptosis in S49 cells. FASEB J 8: 639-645, 1994.
20. 20. Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC and Raff MC, Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361: 365-369, 1993.
21. 21. Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ, Waterfield MD and Downward J, Phosphatidylinositol-3-OH kinase as a direct target of RAS. Nature 370: 527-532, 1994.
22. 22. Liscovitch M and Cantley LC, Lipid second messengers. Cell 77: 329-334, 1994.
23. 23. Vojtek AB, Hollenberg SM and Copper JA, Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 74: 205-214, 1993.
24. 24. Arrick BA and Nathan CF, Glutathione metabolism as a determinant of therapeutic efficacy: A review. Cancer Res 44: 4224-4232, 1984.
25. 25. Armstrong DK, Gordon GB, Hilton J, Streeper RT, Colvin OM and Davidson NE, Programmed cell death in an estrogen-independent human breast cancer cell line, MDA-MB-468. Cancer Res 52: 1416-1421, 1992.
26. 26. Sklar MD, The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation. Science 239: 645-647, 1988.
27. 27. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O and Korsmeyer SJ, bcl-2 Inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67: 879-898, 1991.
28. 28. Allsopp TE, Wyatt S, Paterson HF and Davies AM, The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 73: 295-307, 1993.
29. 29. Fisher TC, Milner AE, Gregory CD, Jackman AL, Wynne Aherne G, Hartley JA, Dive C and Hickman JA, bcl-2 Modulation of apoptosis induced by anticancer drugs: Resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res 53: 3321-3326, 1993.
30. 30. Kinoshita T, Yokota T, Arai KI and Miyajima A, Regulation of Bcl-2 expression by oncogenic Ras protein in hematopoietic cells. Oncogens 10: 2207-2212, 1995.
31. 31. Fairbairn LJ, Cowling GJ, Dexter TM, Rafferty JA and Margison GP, Bcl-2 delay of alkylating agent-induced apoptosis death in murine hemopoietic stem cell line. Mol Carcinogenesis 11: 49-55, 1994.
32. 32. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T, p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849, 1993.
33. 33. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH, Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849-852, 1993.